Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02261649 : Impact of Cerebellar Mass Resection on Pain Processing
PhaseN/A
AgesMin: 6 Years Max: 38 Years
Eligibility
Inclusion Criteria for Patients:

- Age 6?18 years old at the time of surgery.

- Between the ages of 6?38 years old at the time of participation

- Pain and/or behavioral changes subsequent to cerebellar resection.

- Good physical health excluding symptoms directly related to cerebellar resection

- Resection limited to a single cerebellar posterior hemisphere (can be right or left)

- Within 20 years of surgery

- No paralysis/hemiparesis

- No treatment other than surgical resection

- Ability to perform tasks to measure thresholds (button press) and tolerance (withdraw
hand from water bath)

- English speaking sufficient to comprehend and provide assent with parental assistance
or consent if over the age of 18

- Ability to lie still for a 30 minute MRI session

Inclusion Criteria for Healthy Control Volunteers:

- No paralysis/hemiparesis

- Ability to perform tasks to measure thresholds (button press) and tolerance (withdraw
hand from water bath)

- English speaking sufficient to comprehend and provide assent with parental assistance
or consent if over the age of 18

- Ability to lie still for a 30 minute MRI session

Exclusion Criteria for Patients and Healthy Control Volunteers:

- Claustrophobia

- Significant medical (e.g. asthma, renal, cardiac, gastrointestinal or immunological)
or brain? related disorders (e.g. seizures, autism, psychiatric conditions such as
severe depression, psychosis).

- Magnetic implants of any type (including metallic braces, dental bridges, crowns,
retainers, orthodontic devices, etc)

- Weight > 285 pounds (weight limit of the fMRI table)

- History of drug abuse or positive drug screen

- Positive pregnancy screen

- Use of antidepressants or anticonvulsants, excepting patient usage after resection

- Significant alcohol history (ingestion of 5 or more glasses (>40 oz) of alcohol per
week)

- Tattoos containing metallic ink on the neck, shoulders, upper arm and head (which
could heat up in the scanner, and potentially cause blistering or burning)

- Cardiac pacemakers

- Aneurysm clips and other vascular stents, filters, clips or other devices

- Prosthetic heart valves

- Other prostheses

- Neuro?stimulator devices

- Implanted infusion pumps

- Cochlear (ear) implants

- Ocular (eye) implants or known metal fragments in eyes

- Exposure to shrapnel or metal filings (sheet metal workers, welders, and others)

- Other metallic surgical hardware in vital areas

- Participants that require anesthesia to complete an MRI scan

- Receipt of a medication via transdermal patch
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02261649      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740